SS
TARS icon

SBI Securities’s Tarsus Pharmaceuticals TARS Stock Holding History

SBI Securities’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63 Sell
1
-34
-97% -$2.17K ﹤0.01% 3620
2026
Q1 		$2.46K Buy
35
+33
+1,650% +$2.31K ﹤0.01% 2343
2025
Q4 		$164 Sell
2
-51
-96% -$3.81K ﹤0.01% 3272
2025
Q3 		$3.15K Buy
53
+52
+5,200% +$2.56K ﹤0.01% 2241
2025
Q2 		$41 Hold
1
– – ﹤0.01% 3761
2025
Q1 		$51 Sell
1
-3
-75% -$148 ﹤0.01% 3648
2024
Q4 		$221 Buy
+4
New +$182 ﹤0.01% 3200

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SBI Securities's TARS Position: Q2 2026 in Review

SBI Securities reduced its Tarsus Pharmaceuticals (TARS) stake by 97% in Q2 2026, selling an estimated $2.17K and leaving 1 share worth $63. The position accounts for ﹤0.01% of the portfolio, ranked #3620.

SBI Securities first reported a position in TARS in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.15K in Q3 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • SBI Securities held 1 share of Tarsus Pharmaceuticals worth $63 as of Q2 2026.
  • SBI Securities sold 34 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $2.17K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3620 holding.
  • SBI Securities first reported a position in Tarsus Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Tarsus Pharmaceuticals position peaked at $3.15K in Q3 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.